Form 4 for RMD ResMed|
Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-02 · accession 0000943819-25-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-03 | 2025-09-02 | RMD | Sandercock Brett | CFO | M - OptEx | $101.64 | +2,000 | 90.7K | +2% | +$203.3K |
| D | 2025-09-03 | 2025-09-02 | RMD | Sandercock Brett | CFO | S - Sale+OE | $270.77 | -3,000 | 87.7K | -3% | -$812.3K |
| D | 2025-09-03 | 2025-09-02 | RMD | Sandercock Brett | CFO | M - OptEx | $0.00 | -2,000 | 4,000 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-09-02 | M | A | 2,000 | $101.64 | 90,745 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2025-09-02 | S | D | 3,000 | $270.77 | 87,745 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2025-09-02 | M | D | 2,000 | $0.00 | 4,000 | D | $101.64 · 2019-11-11 to 2025-11-14 | 2,000 ResMed Common Stock | (F2) Represents date options first become exercisable. Options vest 1/3 per year. |